• GreenLight Biosciences Receives $3.3 Million Grant

    10 days ago - By Green Light Biosciences

    GreenLight Biosciences Receives $3.3 Million Grant to Develop Sickle Cell Disease Cure Using mRNA Gene Therapy blue double helix models on background
    BOSTON, Sept. 15, 2020 - GreenLight Biosciences has received a $3.3 million grant from the Bill & Melinda Gates Foundation to develop new mRNA-based gene therapies for Sickle Cell Disease and other global health challenges.
    The funding will support GreenLight's research and testing of affordable therapies using the company's novel messenger RNA approach to gene editing. mRNA technology is already being used to develop vaccine candidates for...
    Read more ...